|
1
|
Parisi R, Symmons DP, Griffiths CE and
Ashcroft DM: Identification and Management of Psoriasis and
Associated ComorbidiTy (IMPACT) project team. Global epidemiology
of psoriasis: A systematic review of incidence and prevalence. J
Invest Dermatol. 133:377–385. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
von Csiky-Sessoms S and Lebwohl M: What's
new in psoriasis. Dermatol Clin. 37:129–136. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Christophers E and van de Kerkhof PCM:
Severity, heterogeneity and systemic inflammation in psoriasis. J
Eur Acad Dermatol Venereol. 33:643–647. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Golińska J, Sar-Pomian M and Rudnicka L:
Dermoscopic features of psoriasis of the skin, scalp and nails-a
systematic review. J Eur Acad Dermatol Venereol. 33:648–660.
2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hwang YJ, Jung HJ, Kim MJ, Roh NK, Jung
JW, Lee YW, Choe YB and Ahn KJ: Serum levels of LL-37 and
inflammatory cytokines in plaque and guttate psoriasis. Mediators
Inflamm. 2014(268257)2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Menter A, Strober BE, Kaplan DH,
Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro
KM, Davis DMR, et al: Joint AAD-NPF guidelines of care for the
management and treatment of psoriasis with biologics. J Am Acad
Dermatol. 80:1029–1072. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Elmets CA, Leonardi CL, Davis DMR, Gelfand
JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM,
Elewski BE, et al: Joint AAD-NPF guidelines of care for the
management and treatment of psoriasis with awareness and attention
to comorbidities. J Am Acad Dermatol. 80:1073–1113. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Guo WT and Wang Y: Dgcr8 knockout
approaches to understand microRNA functions in vitro and in vivo.
Cell Mol Life Sci. 76:1697–1711. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Saliminejad K, Khorram Khorshid HR,
Soleymani Fard S and Ghaffari SH: An overview of microRNAs:
Biology, functions, therapeutics, and analysis methods. J Cell
Physiol. 234:5451–5465. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Asadzadeh Z, Mansoori B, Mohammadi A,
Aghajani M, Haji-Asgarzadeh K, Safarzadeh E, Mokhtarzadeh A, Duijf
PHG and Baradaran B: microRNAs in cancer stem cells: Biology,
pathways, and therapeutic opportunities. J Cell Physiol.
234:10002–10017. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Basso MF, Ferreira PCG, Kobayashi AK,
Harmon FG, Nepomuceno AL, Molinari HBC and Grossi-de-Sa MF:
MicroRNAs and new biotechnological tools for its modulation and
improving stress tolerance in plants. Plant Biotechnol J.
17:1482–1500. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hou T, Liao J, Zhang C, Sun C, Li X and
Wang G: Elevated expression of miR-146, miR-139 and miR-340
involved in regulating Th1/Th2 balance with acute exposure of fine
particulate matter in mice. Int Immunopharmacol. 54:68–77.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tu Z, Xiong J, Xiao R, Shao L, Yang X,
Zhou L, Yuan W, Wang M, Yin Q, Wu Y, et al: Loss of miR-146b-5p
promotes T cell acute lymphoblastic leukemia migration and invasion
via the IL-17A pathway. J Cell Biochem. 120:5936–5948.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kirchmeyer M, Servais FA, Hamdorf M,
Nazarov PV, Ginolhac A, Halder R, Vallar L, Glanemann M, Rubie C,
Lammert F, et al: Cytokine-mediated modulation of the hepatic
miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple
targets. J Leukoc Biol. 104:987–1002. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yan M, Yang X, Shen R, Wu C, Wang H, Ye Q,
Yang P, Zhang L, Chen M, Wan B, et al: miR-146b promotes cell
proliferation and increases chemosensitivity, but attenuates cell
migration and invasion via FBXL10 in ovarian cancer. Cell Death
Dis. 9(1123)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yu C, Zhang L, Luo D, Yan F, Liu J, Shao
S, Zhao L, Jin T, Zhao J and Gao L: MicroRNA-146b-3p promotes cell
metastasis by directly targeting NF2 in human papillary thyroid
cancer. Thyroid. 28:1627–1641. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nakasa T, Miyaki S, Okubo A, Hashimoto M,
Nishida K, Ochi M and Asahara H: Expression of microRNA-146 in
rheumatoid arthritis synovial tissue. Arthritis Rheum.
58:1284–1292. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Martínez-Hernández R, Sampedro-Núñez M,
Serrano-Somavilla A, Ramos-Leví AM, de la Fuente H, Triviño JC,
Sanz-García A, Sánchez-Madrid F and Marazuela M: A MicroRNA
signature for evaluation of risk and severity of autoimmune thyroid
diseases. J Clin Endocrinol Metab. 103:1139–1150. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Venkatesha SH, Dudics S, Song Y, Mahurkar
A and Moudgil KD: The miRNA expression profile of experimental
autoimmune encephalomyelitis reveals novel potential disease
biomarkers. Int J Mol Sci. 19(3990)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wallace AB: The exposure treatment of
burns. Lancet. 1:501–504. 1951.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fredriksson T and Pettersson U: Severe
psoriasis-oral therapy with a new retinoid. Dermatologica.
157:238–244. 1978.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cho S, Lee HM, Yu IS, Choi YS, Huang HY,
Hashemifar SS, Lin LL, Chen MC, Afanasiev ND, Khan AA, et al:
Differential cell-intrinsic regulations of germinal center B and T
cells by miR-146a and miR-146b. Nat Commun. 9(2757)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang Z, Dai X, Qi J, Ao Y, Yang C and Li
Y: Astragalus mongholicus (Fisch.) bge improves peripheral treg
cell immunity imbalance in the children with viral myocarditis by
reducing the levels of miR-146b and miR-155. Front Pediatr.
6(139)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Curtale G, Mirolo M, Renzi TA, Rossato M,
Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4
signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA.
110:11499–11504. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Echavarria R, Mayaki D, Neel JC, Harel S,
Sanchez V and Hussain SN: Angiopoietin-1 inhibits toll-like
receptor 4 signalling in cultured endothelial cells: Role of
miR-146b-5p. Cardiovasc Res. 106:465–477. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Park H, Huang X, Lu C, Cairo MS and Zhou
X: MicroRNA-146a and microRNA-146b regulate human dendritic cell
apoptosis and cytokine production by targeting TRAF6 and IRAK1
proteins. J Biol Chem. 290:2831–2841. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Croci S, Zerbini A, Boiardi L, Muratore F,
Bisagni A, Nicoli D, Farnetti E, Pazzola G, Cimino L, Moramarco A,
et al: MicroRNA markers of inflammation and remodelling in temporal
arteries from patients with giant cell arteritis. Ann Rheum Dis.
75:1527–1533. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hermann H, Runnel T, Aab A, Baurecht H,
Rodriguez E, Magilnick N, Urgard E, Šahmatova L, Prans E,
Maslovskaja J, et al: miR-146b probably assists miRNA-146a in the
suppression of keratinocyte proliferation and inflammatory
responses in psoriasis. J Invest Dermatol. 137:1945–1954.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Grine L, Dejager L, Libert C and
Vandenbroucke RE: An inflammatory triangle in psoriasis: TNF, type
I IFNs and IL-17. Cytokine Growth Factor Rev. 26:25–33.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang WM and Jin HZ: Interleukin-6 in
psoriasis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 40:284–288.
2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
32
|
Mease PJ: Inhibition of interleukin-17,
interleukin-23 and the TH17 cell pathway in the treatment of
psoriatic arthritis and psoriasis. Curr Opin Rheumatol. 27:127–133.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hao JQ: Targeting interleukin-22 in
psoriasis. Inflammation. 37:94–99. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Viladomiu M, Hontecillas R, Pedragosa M,
Carbo A, Hoops S, Michalak P, Michalak K, Guerrant RL, Roche JK,
Warren CA and Bassaganya-Riera J: Modeling the role of peroxisome
proliferator-activated receptor γ and microRNA-146 in mucosal
immune responses to Clostridium difficile. PLoS One.
7(e47525)2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Cai F, Wu F, Cao J and Chen X:
MicroRNA-146b-3p regulates the development and progression of
cerebral infarction with diabetes through RAF1/P38MAPK/COX-2
signaling pathway. Am J Transl Res. 10:618–628. 2018.PubMed/NCBI
|
|
36
|
Weng Z, Patel AB, Vasiadi M, Therianou A
and Theoharides TC: Luteolin inhibits human keratinocyte activation
and decreases NF-κB induction that is increased in psoriatic skin.
PLoS One. 9(e90739)2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 361:496–509. 2009.PubMed/NCBI View Article : Google Scholar
|
